Hypothalamic-Pituitary-Adrenal (HPA)-Axis Study in Pediatric Subjects With Perennial Allergic Rhinitis (PAR)

Inclusion Criteria:

- Informed consent/(assent - if applicable)

- Male or female subjects 6-11 years of age

- General good health

- A documented history of PAR to a relevant perennial allergen for a minimum of 12
months

- Other criteria apply

Exclusion Criteria:

- Pregnancy, nursing, or plans to become pregnant or donate gametes

- Participation in any investigational drug study within the 30 days preceding the
Screening Visit 1 (SV1)

- Previous participation in a BDP nasal aerosol study as a randomized subject

- A known hypersensitivity to any corticosteroid or any of the excipients in the study
medication formulation

- History of physical findings of nasal pathology, including nasal polyps or other
clinically significant respiratory tract malformations

- History of a respiratory infection or disorder within the 14 days preceding the
Screening Visit 1 (SV1)

- Use of any prohibited concomitant medications within the prescribed (per protocol)
withdrawal periods prior to the Screening Visit 1 (SV1)

- Other criteria apply

- Current smoker or current user of tobacco products at any time during the study;
history of smoking or use of tobacco products within the past year